EYE

0.00%

22.0¢ nova eye medical limited

What makes iTrack Advance so special?, page-7

First 7 Last

Share
Profile

Follow
HoopsOz

12 Posts.

17/05/24

11:17

Post #: 73874825
Share

Originally posted by TheAnalyst007: ↑

The US market is the focus for the company at the moment, that's where the growth is happening and is where 99% of marketing resources are being allocated. It also makes up the vast majority of their revenue. Last half that was up 65%, first couple months of this year were also up a similarly high rate. That was on a reasonably large base and before the significant expansion in their sales team (from only 6 reps previously) and marketing effort though, and based on an explosion in social media activity around iTrack Advance and significant increase in their presence at the major conferences, it seems fairly likely we will see this growth rate accelerate (particularly in the second half of calendar year 2025, but also the current half as well). Given they're not yet focused on the global market outside the US, global growth has been lagging (they have existing revenue from the previous device) which makes the over all figure look a little less exciting. However I suspect when they focus more resources outside the US, and they get more approvals in these markets, the growth rate will be as strong as it has been in the USA (particularly in China).

They have a large number of patents protecting the key features of their device, thanks to originally pioneering the canaloplasty space with their original iTrack device. Sight Sciences tried to create a similar device, but it's not even close. It can only do half of an eye at a time (not the full eye all at once), has no navigational system and no pressurised visco delivery (which means they get about 10% of the strength of iTrack Advance - requiring the use of an additional tearing procedure).

Expand

Appreciate the views.

What would you consider as the key risks?

Competition?
If the US requires significant marketing to get traction, do they have enough funding with the last CR to keep momentum up?

EYE Price at posting: 24.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce's R327 found effective against E.coli during clinical trial

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

There are more pages in this discussion • 8 more messages in this thread...

First 7 Last

Add EYE (ASX) to my watchlist

(20min delay)
Last 22.0¢		Change 0.000(0.00%)		Mkt cap ! $50.34M

Open	High	Low	Value	Volume
22.5¢	22.5¢	21.0¢	$95.62K	444.6K

Buyers (Bids)

No.	Vol.	Price($)
3	52740	21.5¢

Sellers (Offers)

Price($)	Vol.	No.
22.5¢	73205	2

View Market Depth

No.	Vol.	Price($)
3	52740	0.215
1	131378	0.210
4	91540	0.205
17	405320	0.200
1	3000	0.195

Price($)	Vol.	No.
0.225	73205	2
0.230	38950	4
0.235	100000	1
0.245	11000	1
0.250	49617	2

Last trade - 16.10pm 28/06/2024 (20 minute delay)

EYE (ASX) Chart

What makes iTrack Advance so special?, page-7

Recce's R327 found effective against E.coli during clinical trial

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

Ava Risk Group expands US presence with A$0.7M Substation Deal

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

What makes iTrack Advance so special?, page-7

Top Stories

Recce's R327 found effective against E.coli during clinical trial

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Microcap Wrap: 5 explorers with news out today

Ava Risk Group expands US presence with A$0.7M Substation Deal

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News